Current status of cell-based interventions in Japan.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 36055190.
- Also identified by DOI 10.1016/j.stem.2022.08.003.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The Act on the Safety of Regenerative Medicine regulates cell-based interventions in Japan. Recent revisions to the law require disclosure of explanatory and consent materials for interventions seeking approval. In this Forum, we present an updated analysis of the status and challenges facing the Japanese regulatory framework.
Medical subject headings
- Regenerative Medicine